HeartWare Presentation At The Lazard Capital Markets 9th Annual Healthcare Conference To Be Webcast

  HeartWare Presentation At The Lazard Capital Markets 9th Annual Healthcare
                           Conference To Be Webcast

PR Newswire

FRAMINGHAM, Mass. and SYDNEY, Nov. 9, 2012

FRAMINGHAM, Mass. and SYDNEY, Nov. 9, 2012 /PRNewswire/ -- HeartWare
International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less
invasive, miniaturized circulatory support technologies that are
revolutionizing the treatment of advanced heart failure, today announced that
CEO Doug Godshall is scheduled to present at the Lazard Capital Markets 9^th
Annual Healthcare Conference at 10:00 a.m. EST on Tuesday, November 13, 2012.
The conference is being held November 13-14, 2012, at The Pierre Hotel in New
York City.

A live webcast of the Company's presentation at the conference will be
available via a link provided at www.heartware.com. A replay of the webcast
will be available for 90 days at the site after the presentation.

About HeartWare International
HeartWare International develops and manufactures miniaturized implantable
heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients
suffering from advanced heart failure. The HeartWare^® Ventricular Assist
System features the HVAD^® pump, a small full-output circulatory support
device (up to 10L/min flow) designed to be implanted next to the heart,
avoiding the abdominal surgery generally required to implant competing
devices. HeartWare has received CE Marking for the HeartWare System in the
European Union and TGA approval in Australia. The device is currently the
subject of United States clinical trials for two indications:
bridge-to-transplant and destination therapy. For additional information,
please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000^® and its
securities are publicly traded on The NASDAQ Stock Market and the Australian
Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of
HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864

SOURCE HeartWare International, Inc.

Website: http://www.heartware.com
 
Press spacebar to pause and continue. Press esc to stop.